Spin your science into gold: Direct to consumer marketing within social media platforms

Work

Volumn 41, Issue SUPPL.1, 2012, Pages 4494-4502

  Egilman, David ^a   Druar, Nicholas M ^b  

^a BROWN UNIVERSITY   (United States)

^b Never Again Consulting   (United States)

Author keywords

direct to consumer; pharmaceutical; social media; web 2.0

Indexed keywords

DRUG INDUSTRY; ETHICS; FRAUD; HUMAN; LEGAL ASPECT; MARKETING; REVIEW; SOCIAL MEDIA; WEBCAST;

DRUG INDUSTRY; FRAUD; HUMANS; MARKETING; SOCIAL MEDIA; WEBCASTS AS TOPIC;

EID: 84859814443     PISSN: 10519815     EISSN: None     Source Type: Journal    
DOI: 10.3233/WOR-2012-0751-4494     Document Type: Conference Paper

References (94)

1. Prescribing Information - Tasigna. October 2007. http://www.accessdata. fda.gov/drugsatfda-docs/label/2007/022068lbl.pdf. March 20, 2011.
2. YouTube. January 11, 2011. http://topics.nytimes.com/top/news/business/ companies/youtube/index.html. March 20, 2011.
3. (2001). Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use http://www.ema.europa.eu/docs/en-GB/document-library/Regulatory- and-procedural-guideline/2009/10/WC500004481.pdf.
4. (2005) Carol Ernst v. Merck & Co. Inc. Defendent's Opening Statement. Brazoria County, Texas. 5. (2005). Frist calls for voluntary moratorium on DTC. 07/01/2005. http://www.mmm-online.com/frist-callsfor-voluntary-moratorium-on- dtc/article/22808/.
5. (2006) At-Home Genetic Tests: A Healthy Dose of Skepticism May Be the Best Prescription. In: Commission FT, editor.
6. Bayer Reprimanded for Promotional Tweets. http://www.combinedmedia.ie/ health/blog/bayerreprimanded-for-promotional-tweets. 07/20/2011.
7. Abrams T (2009) Warning Letter: NDA# 21-692 ULTRAM® ER (tramadol HCl) Extended-Release Tablets MACMIS # 17464. In: Weldon W, editor. Titusville.
8. Administration USFaD. DDMAC Organization Listing. 06/23/2011. http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm154886.htm. 08/20/2011.
9. Administration USFaD. Warning Letters and Notice of Violation Letters to Pharmaceutical Companies. 02/23/2011. http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/ WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/default.htm. 08/20/2011.
10. Administration" FaD (1999) Attitudes and Behaviors Associated with Direct-to-Consumer (DTC) Promotion of Prescription Drugs: Main Survey Results. In: Center for Drug Evaluation and Research DoDM, Advertising, and Communications, editor.
11. Angwin J, Stecklow S (2010) 'Scrapers' Dig Deep for Data on Web. Wall Street Journal.
12. Arnold M. DDMAC warns J&J on Ultram webcast. http://www.mmm-online. com/ddmac-warns-jj-onultram-webcast/article/137152/. 07/15/2011.
13. Arnold M. Much ado about mommy bloggers, mobile apps and paid posts. http://www.mmmonline.com/much-ado-about-mommy-bloggers-mobileapps-and-paid- posts/article/197410/. 07/19/2011.
14. Baird PA (2002) Identification of genetic susceptibility to common diseases: the case for regulation. Perspect Biol Med 45: 516-528.
15. Bell RA, Kravitz RL, Wilkes MS (1999) Direct-toconsumer prescription drug advertising and the public. J Gen Intern Med 14: 651-657.
16. Berggren M. (2011). Similac iPhone App does NOT support breastfeeding.marketing mama: Accessed: http://marketingmama.com/similac-iphone- app-doesnot-support-breastfeeding-2.
17. Bilton N. Twitter Turns Five. March 21, 2011. http://bits.blogs.nytimes. com/2011/03/21/twitter-turnsfive/?scp=2&sq=twitter&st=cse. March 22, 2011.
18. Blackburn W. Unbranded Web Sites: Whats your strategy?ePharma Rx: Accessed: http://blog.intouchsol.com/2008/09/do-all-of-yourunbranded-sites-have. html.
19. Burton B (2004) Drug industry to fight New Zealand's move to ban direct to consumer advertising. BMJ 328: 1036.
20. Chester J, Mierzwinski E, Simpson J, Dixon P Complaint, Request for Investigation, Public Disclosure, Injunction, and Other Relief: Google, Microsoft, QualityHealth, WebMD, Yahoo, AOL, HealthCentral, Healthline, Everyday Health, and Others Named Below.
21. Clinard MB (1990) Corporate corruption : the abuse of power. New York: Praeger. xi, 215 p. p.
22. Co. A. About Aventine HealthSciences. 2009. http://www.aventinehealth. com/about/. 08/16/2011.
23. Connolly A. (2011). EU Ban on Drugmaker-Patient Communication Under Review. 07/28/2011. http://www.bloomberg.com/news/2011-07-26/eu-plansreview-of- ban-on-drugmaker-patient-communications-1-.html.
24. Connors K. (2011). What We'd "Like": FDA's Social Media Guidance. 08/16/2011. http://www.phrma.org/catalyst/what-wed-fdas-socialmedia- guidance.
25. Davis JJ, Cross E, Crowley J (2007) Pharmaceutical websites and the communication of risk information. Journal of health communication 12: 29-39.
26. DEdwood Amazing domino video for Restless Legs. 07/20/2011. http://www.youtube.com/watch?v=2bBMKtRm898.
27. Dresner M. (2011). Thoughts on ePharma Summit 2011 Day 1 - Pharmaguy's Perspective.ePharma Summit: Accessed: http://www.epharmasummitblog.com/2011/02/ epharma-day-one-guest-recap.html.
28. Dyer C (1999) Incontinence campaign tests limits of advertising rules. BMJ 319: 591.
29. Facebook. Press Room - Statistics. http://www.facebook.com/press/info. php?statistics. February 20, 2011.
30. Frosch DL, Grande D, Tarn DM, Kravitz RL (2010) A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health 100: 24-32.
31. Fruchart J, Sacks F, Herman M. Editorial: ACCORD Lipid Study brings new hope to people with type 2 diabetes and atherogenic dyslipidemia. 03/14/2010. http://www.r3i.org/pages/editorial.asp?id=21. 8/9/2011.
32. Gerstein HC, Miller ME, Byington RP, Goff DC, Jr., Bigger JT, et al. (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559.
33. Goddard KA, Robitaille J, Dowling NF, Parrado AR, Fishman J, et al. (2009) Health-related direct-toconsumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis. Public Health Genomics 12: 92-104.
34. Gray S. (2010). Drug Companies Take Their Pitch to Social Media. Time. 12/17/2010. http://www.time.com/time/health/article/0,8599,2037568,00.html.
35. Haga SB, Khoury MJ, Burke W (2003) Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nature genetics 34: 347-350.
36. Hansen RA, Shaheen NJ, Schommer JC (2005) Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising. Clinical therapeutics 27: 1478-1487.
37. Harris G. (2009). Drug Makers Are Advocacy Group's Biggest Donors. New York Times. 10/21/2009. http://www.nytimes.com/2009/10/22/health/22nami.html.
38. Hensley S. (2007). Pfizer Follows Docs Online With Sermo.Health Blog: Wall Street Journal. Accessed: http://blogs.wsj.com/health/2007/10/15/pfizer- followsdocs-online-with-sermo/.
39. Hudson K, Javitt G, Burke W, Byers P (2007) ASHG Statement* on direct-to-consumer genetic testing in the United States. Obstet Gynecol 110: 1392-1395.
40. Huh J, Cude BJ (2004) Is the information "fair and balanced" in direct-to-consumer prescription drug websites? Journal of health communication 9: 529-540.
41. Husten L. (2010). Residual Risk Reduction Initiative: Promotion or Education? .CardioBrief: Accessed: http://cardiobrief.org/2010/04/18/residual- riskreduction-initiative-promotion-or-education.
42. Initiative RRR. How to support the R3i Foundation? http://www.r3i.org/ pages/Support.asp.
43. Kaphingst KA, Rudd RE, Dejong W, Daltroy LH (2005) Comprehension of information in three direct-toconsumer television prescription drug advertisements among adults with limited literacy. Journal of health communication 10: 609-619.
44. Kaplan A, Haenlein M (2010) Users of the world, unite! The challenges and opportunities of Social Media. Business Horizons 53: 59-68.
45. Kaye J (2008) The regulation of direct-to-consumer genetic tests. Hum Mol Genet 17: R180-183.
46. Khosla P, Khosla A (2011) Direct to consumer advertising of prescription drugs on internet: A Boon or a Curse. Indian J Pharmacol 43: 483-484.
47. Kim S, Mayhorn C, Wogalter M. (2010). Use of information sources referenced in and attitudes about televised DTC prescription drug advertisements 54, pp. 1880-1884.
48. Koberstein W (2000) DTC Excellence awards. Pharmaceutical Executive 20: 156-159.
49. Kutz G (2006) Testimony Before the Special Committee on Aging, U.S. Senate: Nutrigenetic Testing: Tests Purchased from Four Web Sites Mislead Consumers. In: Office USGA, editor.
50. Laboratories A. Similac. 2011. http://similac.com/app.08/23/2011.
51. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, et al. (2002) Timing of new black box warnings and withdrawals for prescription medications. JAMA 287: 2215-2220.
52. Law MR, Majumdar SR, Soumerai SB (2008) Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study. BMJ 337: a1055.
53. Lee SS, Crawley L (2009) Research 2.0: social networking and direct-to-consumer (DTC) genomics. The American journal of bioethics : AJOB 9: 35-44.
54. Lexchin J, Mintzes B (2002) Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No. Journal of Public Policy & Marketing 21: 194-201.
55. Lyles A (2002) Direct marketing of pharmaceuticals to consumers. Annu Rev Public Health 23: 73-91.
56. Mack J. Alli's New Marketing Strategy: Enhance Product Claims, Cast "Treatment Effects" as a Benefit!Pharma Marketing Blog: Accessed: http://pharmamkting.blogspot.com/2009/09/allis-newmarketing-strategy-enhance. html.
57. Mack J. Pfizer has a Gold Mine in Sermo!Pharma Marketing Blog: Accessed: http://pharmamkting.blogspot.com/2007/10/pfizer-hasgold-mine-in-sermo.html.
58. Mack J. Question Everything.Pharma Marketing Blog: Accessed: http://pharmamkting.blogspot.com/2006/07/questioneverything.html.
59. Mack J. (2011). Brits Beat FDA & PhRMA: Issue Social Media Guidance for Pharma. This BI Tweet May Not Pass Muster. Pharma Marketing Blog. 04/05/2011. http://pharmamkting.blogspot.com/2011/04/brits-beatfda-phrma-issue- social-media.html.
60. Miller CC. (2011). Google Reaches $500 Million Settlement With Government. New York Times Blog. 08/24/2011. http://bits.blogs.nytimes.com/2011/ 08/24/googlereaches-500-million-settlement-withgovernment/?ref=business.
61. Mintzes B (2002) For and against: Direct to consumer advertising is medicalising normal human experience: For. BMJ 324: 908-909.
62. Mintzes B. (2006). Direct-to-Consumer Advertising of Prescription Drugs in Canada. http://www.healthcouncilcanada.ca/docs/papers/2006/hcc-dtc- advertising-200601-e-v6.pdf.
63. Mulligan L (2011) You can't say that on television: constitutional analysis of a direct-to-consumer pharmaceutical advertising ban. Am J Law Med 37: 444-467.
64. Mykitiuk R (2004) Caveat emptor: direct-to-consumer supply and advertising of genetic testing. Clin Invest Med 27: 23-32.
65. Organization WH (1993) Clinical Pharmacological evaluation in drug control. Cogenhagen: WHO.
66. Ostrove NM (2006) Warning Information in the Labeling and Advertising of Pharmaceuticals. In: Wogalter MS, editor. Handbook of Warnings. Mahwah, NJ: Lawrence Erlbaum Associates. pp. 515-535.
67. Palumbo FB, Mullins CD (2002) The Development of Direct-to-Consumer Prescription Drug Advertising Regulation Food and Drug Law Journal 57: 423-443.
68. PhRMA. (2008). PhRMA Guiding Principles Direct to Consumer Advertisements About Prescription Medicines. http://www.phrma.org/sites/default/files/106/ phrma-guiding-principles-dec-08-final.pdf
69. Pines WL (1999) A history and perspective on direct-toconsumer promotion. Food Drug Law J 54: 489-518. 71. racewithinsulin. http://www.twitter.com/ racewithinsulin.March 20, 2011.
70. racewithinsulin. February 26, 2011. http://twitter.com/racewithinsulin/ status/41531733329453056.
71. Rulli KR (2010) NDA # 022068 Tasigna(r) (nilotinib) Capsules MACMIS # 18870. In: Drucker L, editor.
72. Safarik M. (2011). NDA #022560 Atelvia™ (risedronate sodium) delayed-release tablets MACMIS #19629. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/ WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM254562. pdf.
73. Sermo. Get to know Sermo. http://www.sermo.com/client/about/why-sermo.07/ 31/2011.
74. Sermo. Promote your product to 120,000 physicians. http://www.sermo.com/ client/promotion/overview.7/31/2011.
75. Shaw A. (2008). Direct-to-Consumer Advertising (DTC) of Pharmaceuticals. ProQuest Discovery Guides. March 2008. http://www.csa.com/discoveryguides/ direct/review.pdf.
76. Silverman E. (2011). The Op-Ed: Do Pharma & Social Media Not Mix?Pharmalot: Accessed: http://www.pharmalot.com/2011/07/the-op-ed-dopharma- social-media-not-mix/.
77. Silverman E. (2011). Pfizer Facebook Page Is Hacked By Script Kiddies.Pharmalot: Accessed: http://www.pharmalot.com/2011/07/pfizer- facebookpage-is-hacked-by-script-kiddies/.
78. Silversides A (2009) Charter challenge of ban on directto- consumer advertising to be heard by Ontario court in mid-June. CMAJ 181: E5-6.
79. Sweet M (2009) Pharmaceutical marketing and the internet. Australian Prescriber 32: 2-4.
80. System CotAotUDS (2007) The Future of Drug Safety: Promoting and Protecting the Health of the Public. Institute of Medicine.
81. Thomas C. (2009). "Sleazy example" of drug company's reminder ad on Twitter.The Ethical Nag: Accessed: http://ethicalnag.org/2009/09/20/ sleazy-twitter/.
82. Thomaselli R. Big Pharma Taking Steps to Reach Patients With Digital Media. 5/11/2009. http://adage.com/article?article-id=136538. 12/2/2010.
83. Toop L, Mangin D (2007) Industry funded patient information and the slippery slope to New Zealand. BMJ 335: 694-695.
84. Torres C. (2011). More drug companies close Facebook pages as Walls open. The Washington Post. 08/16/2011. http://www.washingtonpost.com/national/ healthscience/more-drug-companies-close-facebook-pagesas-walls-open/2011/08/16/ gIQA1venJJ-story.html.
85. Velo G, Moretti U (2008) Direct-to-consumer information in Europe: the blurred margin between promotion and information. Br J Clin Pharmacol 66: 626-628.
86. Vigilante W, Wogalter M. (2001). Direct-to-consumer (DTC) advertising of prescription medications on the World Wide Web: Assessing the communication of risks,45, pp. 1279-1283.
87. Wang M. (2011). Health Advocacy Groups Take Drug Company Cash-Often Without Full Disclosures, Report Says.The ProPublica Blog: ProPublica. Accessed: http://www.propublica.org/blog/item/healthadvocacy-groups-take-drug-company- cashoftenwithout-full-disclosures.
88. wefollow. Pharmaceutical. http://wefollow.com/twitter/pharmaceutical. March 21, 2011.
89. Weinstein J. (2004). Public Relations: Why Advocacy Beats DTC. Pharmaceutical Executive. 10/01/2004. http://pharmexec.findpharma.com/pharmexec/ article/articleDetail.jsp?id=129300.
90. Whalen J (2006) Web Site Is a Prelude to Glaxo's OTC Weight-Loss Pill. The Wall Street Journal. New York: Wall Street Journal.
91. Wiist WH (2010) The bottom line or public health : tactics corporations use to influence health and health policy, and what we can do to counter them. Oxford ; New York: Oxford University Press. xix, 570 p. p.
92. Wilkes MS, Bell RA, Kravitz RL (2000) Direct-toconsumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood) 19: 110-128.
93. William-Jones B (2006) "Be ready against cancer, now": direct-to-consumer advertising for genetic testing. New Genet Soc 25: 89-107.
94. Williams-Jones B (2003) Where there's a web, there's a way: commercial genetic testing and the Internet. Community Genet 6: 46-57.